4//SEC Filing
Ramelmeier Rolf Andrew 4
Accession 0001209191-20-013232
CIK 0001001233other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 7:33 PM ET
Size
14.2 KB
Accession
0001209191-20-013232
Insider Transaction Report
Form 4
Ramelmeier Rolf Andrew
EVP, Technical Operations
Transactions
- Award
Stock Option (Right-to-Buy)
2020-02-25+110,000→ 110,000 totalExercise: $6.80Exp: 2030-02-24→ Common Stock (110,000 underlying) - Tax Payment
Common Stock
2020-02-25$6.80/sh−1,703$11,580→ 14,128 total - Award
Common Stock
2020-02-25+55,000→ 69,128 total
Footnotes (4)
- [F1]Represents shares underlying the portion of the Restricted Stock Unit that vested on February 25, 2020 surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on February 25, 2020 of $6.80/share, pursuant to the terms of the Issuer's 2018 Equity Incentive Plan.
- [F2]Includes 61 shares acquired by the Reporting Person on October 31, 2019 under the Issuer's 2010 Employee Stock Purchase Plan, as amended. Also included in this total are 2,464 shares resulting from the February 25, 2020 vesting of Reporting Person's February 25, 2019 restricted stock unit grant and 8,333 shares subject to such restricted stock unit grant that will vest in two remaining annual installments on February 25, 2021 and February 25, 2022, resulting in such restricted stock unit grant being vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such date.
- [F3]Represents 55,000 shares subject to restricted stock units granted on February 25, 2020 that will vest in three (3) equal annual installments on each anniversary of the grant date, such that they will be vested in full on the third (3rd) anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer through such dates.
- [F4]One-quarter (1/4) of the option shares vest and become exercisable upon completion of one (1) year of service by the Reporting Person measured from the February 25, 2020 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001789340
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 7:33 PM ET
- Size
- 14.2 KB